896 abstracts found.
Results filter
- Year: 2014 Remove Filter
What can we learn from circulating tumour cells in lung cancer – biomarkers, mouse models, drug resistance and heterogeneity
The targets for tumour immunotherapy mediated by the inflammatory properties of vesicular stomatitis virus (VSV)-based antigen presentation depend upon the tumour’s anatomical site
Computational dissection of intratumour genetic heterogeneity and applications to the study of cancer treatment, evolution and metastasis
Introduction: Optimising care for those living with and beyond cancer – where does primary care fit in?
Primary care views on optimising care for those living with and beyond cancer: findings from a systematic review and GP survey
Pan-RAF inhibitor active in melanomas that are resistant to BRAF or BRAF /MEK inhibitor combinations.
Year: 2014
Session type: Parallel sessions
1Molecular Oncology Group - Cancer Research UK Manchester Institute, Manchester, UK,2Gene and Oncogene Targeting Team - The Institute of Cancer Research, London, UK,3Signal Transduction Team - Cancer Research UK Manchester Institute, Manchester, UK,4Targeted Therapy Team - The Institute of Cancer Research, London, UK,5University of Manchester - Christie NHS Foundation Trust, Manchester, UK
Targeting phosphoinositide 3-kinase for cancer therapy
Year: 2014
Session type: Plenary lectures
1Weill Cornell Medical School, Cornell University, New York, USA
Targeting phosphoinositide 3-kinase for cancer therapy
Year: 2014
Session type: Plenary lectures
1Weill Cornell Medical School, Cornell University, New York, USA
Whither drug discovery: the genetic basis for cancer therapeutics
Year: 2014
Session type: Plenary lectures
1Novartis Institutes for BioMedical Research, Cambridge, USA
Mouse models of malignant glioblastoma multiforme: cancer stem cells and beyond
Year: 2014
Session type: Plenary lectures
1University of Texas Southwestern Medical Center, Dallas, USA
Mouse models of malignant glioblastoma multiforme
Year: 2014
Session type: Plenary lectures
1University of Texas Southwestern Medical Center, Dallas, USA
Whither localised therapies
Year: 2014
Session type: Plenary lectures
1Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Oxford, UK
BACR Tom Connors lecture – Targeting and imaging cancer phenotypes: Focal Adhesion Kinase as a critical regulator of tumour cells and the host immune response
Year: 2014
Session type: Plenary lectures
1Cancer Research UK Edinburgh Centre, University of Edinburgh, Edinburgh, UK
Cancer genomics: state of the science and clinical translation
Year: 2014
Session type: Plenary lectures
1The Genome Institute at Washington University School of Medicine, St Louis, USA